ACR Share Price

Open 0.27 Change Price %
High 0.28 1 Day -0.02 -7.14
Low 0.26 1 Week 0.00 0.00
Close 0.26 1 Month -0.03 -10.34
Volume 22007 1 Year -0.46 -63.89
52 Week High 0.72
52 Week Low 0.22
ACR Important Levels
Resistance 2 0.28
Resistance 1 0.27
Pivot 0.27
Support 1 0.25
Support 2 0.24
ASX Australia Most Active Stocks
LYC 0.15 7.14%
TLS 3.90 0.78%
TLS 3.90 0.78%
TLS 3.90 0.78%
DUE 3.02 1.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
AGO 0.02 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
VKA 0.02 100.00%
CAV 0.02 100.00%
CAV 0.02 100.00%
GMD 0.02 100.00%
GMD 0.02 100.00%
RDS 0.02 100.00%
RDS 0.02 100.00%
RDS 0.02 100.00%
AZZ 0.50 78.57%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
AZS 0.01 -50.00%
AZS 0.01 -50.00%
AIR 0.02 -33.33%
AIR 0.02 -33.33%
More..

Acrux Ltd (ASX: ACR)

ACR Technical Analysis 3
As on 18th Aug 2017 ACR Share Price closed @ 0.26 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.30 & Sell for SHORT-TERM with Stoploss of 0.26 we also expect STOCK to react on Following IMPORTANT LEVELS.
ACR Target for August
1st Target up-side 0.35
2nd Target up-side 0.39
3rd Target up-side 0.43
1st Target down-side 0.25
2nd Target down-side 0.21
3rd Target down-side 0.17
ACR Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.acrux.com.au
ACR Address
ACR
103-113 Stanley Street
West Melbourne, VIC 3003
Australia
Phone: 61 3 8379 0100
Fax: 61 3 8379 0101
ACR Latest News
Interactive Technical Analysis Chart Acrux Ltd ( ACR ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Acrux Ltd
ACR Business Profile
Acrux Limited, a drug delivery company, develops and commercializes a range of patient-preferred and patented pharmaceutical products using its technology to administer proven medicines through the skin. The company’s products include Axiron to treat testosterone deficiency in men; Evamist for menopause symptoms; and Recuvyra pain relief for dogs. Its product under registration comprises Estradiol MDTS for menopause symptoms. The company is also developing Luramist for female HSDD; Nestorone MDTS for contraception; Nicotine MDTS for smoking cessation; and NSAIDs for pain and inflammation. It operates in Australia, accessing international pharmaceutical markets through commercial partners. Acrux was founded in 1998 and is based in West Melbourne, Australia.